What is LabRad Diagnostics?
LabRad Diagnostics specializes in guiding entrepreneurs through the intricate process of launching a laboratory testing business. The company's core offering focuses on the establishment of CLIA mobile phlebotomy laboratories, providing essential steps and regulatory requirements for success in the burgeoning laboratory testing sector. Their services are tailored for individuals and entrepreneurs aiming to enter this specialized market, offering comprehensive support to navigate the complexities of operational setup.
How much funding has LabRad Diagnostics raised?
LabRad Diagnostics has raised a total of $250K across 2 funding rounds:
Debt
$150K
Debt
$100K
Debt (2020): $150K with participation from PPP
Debt (2021): $100K led by PPP
Key Investors in LabRad Diagnostics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for LabRad Diagnostics?
With substantial late-stage funding, LabRad Diagnostics is poised for significant growth and market penetration. The strategic investment suggests a focus on scaling operations, enhancing service offerings, and potentially expanding into new geographical markets or service lines. This capital infusion will likely fuel further development of their guidance platforms and support infrastructure, solidifying their role as a key enabler for new entrants in the laboratory testing industry.
See full LabRad Diagnostics company page
